Peer Review History

Original SubmissionJuly 4, 2025
Decision Letter - Yanbu Guo, Editor

PCOMPBIOL-D-25-01342

Degradation Graphs for Mechanistic Peptidomic Analysis

PLOS Computational Biology

Dear Dr. Hartman,

Thank you for submitting your manuscript to PLOS Computational Biology. After careful consideration, we feel that it has merit but does not fully meet PLOS Computational Biology's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript within 60 days Nov 21 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at ploscompbiol@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pcompbiol/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

* A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. This file does not need to include responses to formatting updates and technical items listed in the 'Journal Requirements' section below.

* A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

* An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, competing interests statement, or data availability statement, please make these updates within the submission form at the time of resubmission. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter

We look forward to receiving your revised manuscript.

Kind regards,

Yanbu Guo, Ph.D.

Academic Editor

PLOS Computational Biology

Virginia Pitzer

Editor-in-Chief

PLOS Computational Biology

Additional Editor Comments (if provided):

Sorry for the delay. Overall, the reviewers felt the manuscript has merit, but made a number of recommendations that should be addressed in the revised version.

Furthermore, while the manuscript was submitted as a Perspective, the editors feel that it is more appropriate as a Research Article or Methods article, in line with the feedback from the reviewers. Please resubmit a revised version (taking into account the critiques) as one or other after reviewing the policies here: https://journals.plos.org/ploscompbiol/s/submission-guidelines#loc-methods-submissions

Journal Requirements:

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: I have the following comments.

1. It is recommended that the Introduction section should include an overview of current mainstream protein degradation models, along with an analysis of their differences and improvements compared to the proposed method. Additionally, the core innovations of this study should be clearly articulated in the Introduction.

2. The experimental validation is currently limited to simulated data and a single experimental dataset (β-actin), with a relatively small dataset size (only 70 peptides). It is suggested to broaden the validation scope by testing on diverse protein types and larger-scale real datasets.

3. The paper lacks performance comparisons between the proposed method and existing methods. It is recommended to include relevant benchmark tests to demonstrate its advantages.

4. The description of the specific implementation details for optimizing the weights of the degradation graph using gradient descent and linear programming is insufficient. It is suggested to provide algorithm pseudocode or flowcharts to enhance clarity and reproducibility.

Reviewer #2: 1 Incorporate any significant numerical findings within the abstract.

2.In the beginning, emphasise the novelties and fresh contributions of your work.

3 Give an overview of earlier research, highlighting what has been accomplished, what is still lacking, and your contributions in relation to those findings.

4 Perform further benchmark analysis to illustrate the benefits or drawbacks of your approach. To assess how much the adoption of your suggested advanced ways improves things, it would be helpful to have more comparisons with some older approaches.

5 Please give github website to release the code with datasets.

6 Please perform parameter analysis and abration experiments.

Reviewer #3: In PCOMPBIOL-D-25-01342 entitled “Degradation Graphs for Mechanistic Peptidomic Analysis”, authors proposed degradation graphs to representing proteolytic processes from peptidomic data, and show a case about how degradation graphs can be used for prediction of graph types.

It should be an interesting work to provide more computational model and biological details of protein and its dynamics in biological system. I have some questions and suggestions:

(1) The main figures should improve and provide more details about the model. For Figure 2a, as the tree structure with root of one protein, all the peptides in the tree should be given variable annotations, which can help understand the relation of variables in the model by Markov chain.

(2) Similarly, in Figure 3a, it is necessary to illustrate the common and specificity between traditional and graph methods.

(3) It is necessary to provide a pseudo-code for the computational framework in the main text.

(4) Authors have provided case application to a small experimental data, which is based on a pool data. It is necessary to provide further deep mechanistic study on larger dataset with control and case samples (e.g. normal and disease samples).

(5) It is suggested to provide some tables to summarize the current available data and method for peptidomic study.

(6) It is better to provide code and data of this study in public domain.

(7) The manuscript must be proofread to eliminate all spelling errors. Such as in Page 8, “TTo address the challenges …”

**********

Reviewers who wish to reveal their identities to the authors and other reviewers should include their name here (optional). These names will not be published with the manuscript, should it be accepted.

Reviewer #1: (No Response)

Reviewer #2: None

Reviewer #3: (No Response)

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

Figure resubmission:

While revising your submission, we strongly recommend that you use PLOS’s NAAS tool (https://ngplosjournals.pagemajik.ai/artanalysis) to test your figure files. NAAS can convert your figure files to the TIFF file type and meet basic requirements (such as print size, resolution), or provide you with a report on issues that do not meet our requirements and that NAAS cannot fix.

After uploading your figures to PLOS’s NAAS tool - https://ngplosjournals.pagemajik.ai/artanalysis, NAAS will process the files provided and display the results in the "Uploaded Files" section of the page as the processing is complete. If the uploaded figures meet our requirements (or NAAS is able to fix the files to meet our requirements), the figure will be marked as "fixed" above. If NAAS is unable to fix the files, a red "failed" label will appear above. When NAAS has confirmed that the figure files meet our requirements, please download the file via the download option, and include these NAAS processed figure files when submitting your revised manuscript.

Reproducibility:

To enhance the reproducibility of your results, we recommend that authors of applicable studies deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Revision 1

Attachments
Attachment
Submitted filename: responses_review1.pdf
Decision Letter - Yanbu Guo, Editor

PCOMPBIOL-D-25-01342R1

Degradation Graphs Reveal Hidden Proteolytic Activity in Peptidomes

PLOS Computational Biology

Dear Dr. Hartman,

Thank you for submitting your manuscript to PLOS Computational Biology. After careful consideration, we feel that it has merit but does not fully meet PLOS Computational Biology's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jan 31 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at ploscompbiol@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pcompbiol/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

* A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. This file does not need to include responses to formatting updates and technical items listed in the 'Journal Requirements' section below.

* A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

* An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, competing interests statement, or data availability statement, please make these updates within the submission form at the time of resubmission. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter

We look forward to receiving your revised manuscript.

Kind regards,

Yanbu Guo, Ph.D.

Academic Editor

PLOS Computational Biology

Virginia Pitzer

Editor-in-Chief

PLOS Computational Biology

Additional Editor Comments (if provided):

Note that two of the reviewers still have some more substantial comments that need to be address, while one has some minor comments regarding the figures. In particular, two of the reviewers ask for some comparison to alternative/simpler methods.

Journal Requirements:

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: I have no other comments.

Reviewer #2: The authors addressed most of my prior comments. However I have several comments as follows,

1. Explicitly distinguish degradation graphs from prior sequence-based degradation models (e.g., sequential multi-step reaction models) beyond brief mentions. Highlight unique contributions to graph structure (directed acyclic design, absorption probability) and how they solve unmet needs in dynamic proteolysis inference from static data.

2.Strengthen the rationale for choosing both gradient descent and linear programming optimization. Explain trade-offs (e.g., flexibility vs. constraint satisfaction) with empirical comparisons (e.g., convergence speed, stability across datasets) to guide users on method selection.

3. Address peptide detection bias: Discuss how incomplete peptide coverage (a key limitation) impacts graph inference and propose mitigation strategies (e.g., imputation methods tailored to degradation logic, or sensitivity analyses on missing peptides).

4. Expand the machine learning section: Test the GraphConv model on more proteases (beyond trypsin/elastase) and real-world datasets (not just simulated data) to validate its ability to capture protease-specific signatures in complex samples.

5. Improve figure annotations: For key figures (e.g., Fig. 2, 4), add labels for biological relevance (e.g., "bottleneck peptide linked to inflammation") and clarify how graph features map to experimental observations.

Reviewer #3: Authors have responded to all my concerned questions, and made certain revisions.

There are a few remaining points:

(1) Fig3f, the numbers in x-axis should be labeled clearly.

(2) Fig5c, there should be P value of significance test of group differences between Diabetes and Healthy.

(3) Fig6c, there should be P value of significance test of group differences between S.aureus and P.aeruginosa.

Reviewer #4: This study achieves significant breakthroughs in the analysis of protein dynamic degradation by constructing an innovative computational framework called the 'degradation graph.' For the first time, this method models protein degradation as a directed acyclic graph (DAG) and introduces the probabilistic flow analysis paradigm (Figures 2a–c), successfully addressing the systematic underestimation problem in traditional proteomics analyses caused by neglecting the order of degradation. By proposing the dual concepts of 'absorption probability' and 'flow quantification,' combined with parameter sensitivity analysis and a multi-dimensional validation system (simulated data in Figure 4, in vitro β-actin data in Figure 3, and diabetic urine and infected wound fluid data in Figures 5–6), the method significantly improves the quantification accuracy of protease activity. Notably, during the revision process, the authors added two critical clinical datasets on diabetes and wound infection and supplemented technical details such as algorithm pseudocode, effectively addressing the initial review comments.

Based on the current quality of the manuscript, it is recommended to address the following issues before acceptance:

1. Although the authors state on page 8 that “there is currently no directly comparable computational framework,” the manuscript lacks a systematic comparison with any simplified baseline methods, making it difficult to intuitively demonstrate the quantitative advantage of the degradation graph. Please include in the supplementary materials a comparison experiment with the conventional "peptide intensity summation method," i.e., directly using observed peptide abundances as protease activity estimates and comparing with the total flow estimates from the degradation graph, further quantifying the "3–4 fold underestimation" mentioned in Figures 3f, 5c, and 6c.

2. Page 18 mentions the problem of "Unidentifiability," but the stability of the model under different initializations or noisy conditions is not systematically evaluated. Please show this as much as possible in the methods or figures, such as the coefficient of variation of edge weights from multiple runs of gradient descent on the same dataset.

3. Please adjust the clarity of textual content in the figures and use vector graphics wherever possible.

This study is highly innovative and practical in terms of conceptual, methodological, and application aspects, has adequately addressed the reviewer comments from the initial draft, and has made significant progress in both theoretical and experimental validation.

I recommend revisions before acceptance, mainly addressing the three points mentioned above to provide further clarification or analysis, thereby enhancing the rigor and persuasiveness of the manuscript.

**********

Have the authors made all data and (if applicable) computational code underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data and code underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data and code should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data or code —e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: None

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Reviewer #4: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

Figure resubmission:

While revising your submission, we strongly recommend that you use PLOS’s NAAS tool (https://ngplosjournals.pagemajik.ai/artanalysis) to test your figure files. NAAS can convert your figure files to the TIFF file type and meet basic requirements (such as print size, resolution), or provide you with a report on issues that do not meet our requirements and that NAAS cannot fix.

After uploading your figures to PLOS’s NAAS tool - https://ngplosjournals.pagemajik.ai/artanalysis, NAAS will process the files provided and display the results in the "Uploaded Files" section of the page as the processing is complete. If the uploaded figures meet our requirements (or NAAS is able to fix the files to meet our requirements), the figure will be marked as "fixed" above. If NAAS is unable to fix the files, a red "failed" label will appear above. When NAAS has confirmed that the figure files meet our requirements, please download the file via the download option, and include these NAAS processed figure files when submitting your revised manuscript.

Reproducibility:

To enhance the reproducibility of your results, we recommend that authors of applicable studies deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Revision 2

Attachments
Attachment
Submitted filename: responses_review_2.pdf
Decision Letter - Yanbu Guo, Editor

Dear Mr Hartman,

We are pleased to inform you that your manuscript 'Degradation Graphs Reveal Hidden Proteolytic Activity in Peptidomes' has been provisionally accepted for publication in PLOS Computational Biology.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Computational Biology.

Best regards,

Yanbu Guo, Ph.D.

Academic Editor

PLOS Computational Biology

Virginia Pitzer

Editor-in-Chief

PLOS Computational Biology

***********************************************************

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: I have no other comments.

Reviewer #2: none

Reviewer #3: Authors have responded to all my concerned questions, and made a revision well.

Reviewer #4: I have carefully reviewed the revised manuscript and the point-by-point response. Overall, the authors have adequately addressed my previous concerns, and I therefore recommend acceptance. Specifically, the authors provided simulation-based quantification showing that the underestimation ratio (Δ) increases with degradation extent/peptidome complexity, thereby more clearly establishing the quantitative advantage over the conventional peptide-intensity summation approach. The revision also includes additional evaluations of unidentifiability and model stability, including analyses of the coefficient of variation of edge weights across different random initializations, as well as sensitivity sweeps over learning rates and training epochs demonstrating that the main conclusions and top features remain consistent once convergence is achieved. These additions substantially strengthen the comparability, robustness, and overall persuasiveness of the method.

**********

Have the authors made all data and (if applicable) computational code underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data and code underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data and code should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data or code —e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: None

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: None

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Reviewer #4: No

Formally Accepted
Acceptance Letter - Yanbu Guo, Editor

PCOMPBIOL-D-25-01342R2

Degradation Graphs Reveal Hidden Proteolytic Activity in Peptidomes

Dear Dr Hartman,

I am pleased to inform you that your manuscript has been formally accepted for publication in PLOS Computational Biology. Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

For Research, Software, and Methods articles, you will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

Thank you again for supporting PLOS Computational Biology and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Livia Horvath

PLOS Computational Biology | Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom ploscompbiol@plos.org | Phone +44 (0) 1223-442824 | ploscompbiol.org | @PLOSCompBiol

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .